Travere Therapeutics (TVTX) EPS (Basic) (2011 - 2026)
Travere Therapeutics (TVTX) posted EPS (Basic) of -$0.01 for Q1 2026, down 101.96% on a QoQ basis from $0.28 in Q4 2025.
Travere Therapeutics (TVTX) EPS (Basic) (2011 - 2026) Analysis & Trends
Travere Therapeutics' EPS (Basic) history runs 16 years deep, the most recent figure standing at -$0.01 for Q1 2026.
- Quarterly EPS (Basic) changed N/A year-over-year to -$0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.26 (up 2902.53% YoY) and the FY2025 annual result came in at $0.28, up 2488.54% from the prior year.
- EPS (Basic) was -$0.01 for Q1 2026 at Travere Therapeutics, down from $0.28 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.14 in Q3 2023 and bottomed at -$0.02 in Q4 2023.
- A 5-year average of $0.33 and a median of $0.12 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 106.83% — and 2025, when it soared 145801.05%.
- Travere Therapeutics' EPS (Basic) stood at $0.31 in 2022, then plunged by 106.83% to -$0.02 in 2023, then surged by 99.1% to -$0.0 in 2024, then surged by 145801.05% to $0.28 in 2025, then tumbled by 101.96% to -$0.01 in 2026.
- Business Quant data shows TVTX's EPS (Basic) at -$0.01 in Q1 2026, $0.28 in Q4 2025, and -$0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Travere Therapeutics | 5.25 Bn | 5.25 Bn | 125.25 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | 0.28 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | 3.14 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.22 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | -1.48 |
| Sep 30, 2021 | -0.59 |
| Jun 30, 2021 | -0.64 |
| Mar 31, 2021 | -0.96 |
| Dec 31, 2020 | -2.56 |
| Sep 30, 2020 | -0.44 |